AI-generated summary
The authors compared low-level laser therapy at 10 or 15 J/cm(2) with a placebo-level dose of 0.1 J/cm(2) in 61 treated and 19 control patients with temporomandibular joint pain. They report that both active doses reduced pain more than placebo, with stronger results in chronic pain, and suggest LLLT may be useful for TMD-related pain.
- Who or what was studied
- Patients with temporomandibular joint disorders, including myofascial pain and TMD arthralgia; 61 in the treatment group and 19 in the control group
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract reports no details on randomization, blinding, or follow-up duration, and the pain outcome was measured only by self-administered questionnaire.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 400 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.